Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

"Exact Sciences团队很自豪能够通过与Humana的合作扩大Cologuard Plus的使用范围，使更多人能够在家中舒适地使用这种革命性的非侵入性结直肠癌筛查测试，"Exact Sciences筛查部门执行副总裁兼总经理Jake Orville表示。

Exact sciences raises 2025 revenue guidance to $3.12B driven by Cologuard Plus launch May 01, 2025 8:47 PM ET Exact Sciences Corporation (EXAS) Stock AI-Generated Earnings Calls Insights 1 Comment ...

That’s what the Cologuard Classic aims to do: not only raise awareness but give patients and survivors hope. And yet, a healthy dose of hope would not be possible without early detection.

Cologuard Plus is a more sensitive version of the original Cologuard that was first approved in 2014. The test is for people 45 and older who are at average risk of colorectal cancer, meaning ...

Madison, Wis.-based Exact Sciences Corp. agreed to a contract with Louisville, Ky.-based Humana to cover its Cologuard colon cancer screening test as an in-network service.

Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members. Effective Jan. 1 ...

And although Exact’s colorectal fecal-based screening test (Cologuard) has been experiencing strong growth, at $1.1 billion of sales in 2021, compared with under $500 million three years ago ...